LEWIS + CLARK PHARMACEUTICALS SUBSIDIARY, INC.

Profile

Company Names

LEWIS + CLARK PHARMACEUTICALS SUBSIDIARY, INC.
LEWIS + CLARK PHARMACEUTICALS, INC.

Addresses

1180 SEMINOLE TRAIL, SUITE 495, CHARLOTTESVILLE, VA 22901

Phone Numbers

434-963-4000

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2012

State Incorporated:

VIRGINIA

Total Amount Raised:

$400,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2016-01-08 
$25,000.00 
$1,700,000.00 
$1,675,000.00 
Equity, Debt 
1
2012-11-06 
$375,000.00 
$750,000.00 
$375,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
C. THOMAS 
 
CARTER 
DIRECTOR
LEWIS + CLARK PHARMACEUTICALS, INC.
THOMAS 
 
CARTER 
DIRECTOR
LEWIS + CLARK PHARMACEUTICALS SUBSIDIARY, INC.   |  LEWIS + CLARK PHARMACEUTICALS, INC.
JOEL 
 
LINDEN 
DIRECTOR
LEWIS + CLARK PHARMACEUTICALS SUBSIDIARY, INC.   |  LEWIS + CLARK PHARMACEUTICALS, INC.
JOEL 
M. 
LINDEN 
DIRECTOR
LEWIS + CLARK PHARMACEUTICALS, INC.
MIETTE 
 
MICHIE 
EXECUTIVE OFFICER, DIRECTOR
LEWIS + CLARK PHARMACEUTICALS SUBSIDIARY, INC.   |  LEWIS + CLARK PHARMACEUTICALS, INC.
LARRY 
 
RODMAN 
EXECUTIVE OFFICER
LEWIS + CLARK PHARMACEUTICALS SUBSIDIARY, INC.   |  LEWIS + CLARK PHARMACEUTICALS, INC.
LARRY 
E. 
RODMAN 
EXECUTIVE OFFICER, DIRECTOR
LEWIS + CLARK PHARMACEUTICALS, INC.
ROBERT 
 
THOMPSON 
EXECUTIVE OFFICER, DIRECTOR
BLUE SPARK TECHNOLOGIES, INC.   |  ESCREEN INC   |  PUNCH BOWL LLC   |  ALGAE BIOSCIENCES CORP.   |  AMERICAN STANDARD ENERGY CORP.   |  LEWIS + CLARK PHARMACEUTICALS SUBSIDIARY, INC.   |  LEWIS + CLARK PHARMACEUTICALS, INC.   |  WHISKY BEER DENVER, LLC   |  PUNCH BOWL AUSTIN, LLC   |  EMERGE DIAGNOSTICS, LLC   |  PBS BRAND CO., LLC   |  EMERGE DIAGNOSTICS, INC   |  SANDEL AVIONICS INC   |  MYLAND CO LLC   |  NRFTA, INC.   |  UNDERLINE INFRASTRUCTURE INC.   |  UNDERLINE INFRASTRUCTURE SERVICES, LLC   |  AMORPHEX THERAPEUTICS HOLDINGS INC.
ROBERT 
D. 
THOMPSON 
EXECUTIVE OFFICER, DIRECTOR
LEWIS + CLARK PHARMACEUTICALS, INC.
JEFFREY 
J. 
TOTTEN 
DIRECTOR
LEWIS + CLARK PHARMACEUTICALS, INC.
EDWARD 
J. 
WILLIAMS 
DIRECTOR
LEWIS + CLARK PHARMACEUTICALS, INC.   |  BONUMOSE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-01-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-01-08 
2013-10-21
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-06 
2012-12-04
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-11-06 
2012-11-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-11-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#